6/29/2009 Assets sold
|
6/22/2009 Link Prospect Therapeutics Inc.'s GCS-100 Has Focused on Developing Treatment for Thr More ...
|
6/15/2009 Link Prospect Therapeutics' In Vitro Studies Demonstrate that GCS-100 Drug Binds to a More ...
|
6/5/2009 Link Ludwig Institute of Cancer Research Ltd., Brussels Branch, Issues Statement Conc More ...
|
5/26/2009 Prospect Therapeutics Press Release 05_26_09.pdf Prospect Therapeutics, Inc.'s GCS-100 Inhibited Blood Vessel Formation in a Vari More ...
|
5/19/2009 Prospect Therapeutics, Inc. 05_19_09.pdf Prospect Therapeutics, Inc.'s GCS-100 Exhibits a Low Toxicity Profile in Cancer More ...
|
5/12/2009 Prospect Therapeutics Assigns All Its Assets to JFFinn_05_12_09.pdf Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A More ...
|
5/7/2009 Prospect Therapeutics Assigns Assets to Joseph F. Finn, Jr. C.P.A. for the Benef More ...
|
6/1/2009 Link Interim Phase 2 Results On Prospect Therapeutics' GCS-100 Presented At The 10th More ...
|